The positive correlation observed between PRG4 level and life expectancy only in patients with low CD44 expression might reflect a failure of PRG4 to saturate CD44 binding site/s, when this receptor is upregulated above a certain threshold, making it unable to overcome tumor-promoting functions of CD44 signaling. The gene discussed is CD44; the disease is neoplasm.